Active replication — ongoing trial, registry, or meta-analysis.
Recent follow-up analyses of ORBITA are confirming the original effect size in real-world data.
TL;DR · AI-generated
In patients with medically treated angina and severe coronary stenosis, PCI did not increase exercise time by more than the effect of a placebo procedure, and the primary endpoint was difference in exercise time increment between groups.
Your position — does this noeme still stand given current evidence?
0% (impossible)
50%
100% (certain)
Proper-scoring-rule preview
Your position is kept on this device until you sign in.
Evidence stream
2 events · 1 snapshot
posterior drift
71% → 71% (0pp · 1 point)
Registry data
Apr 18, 2026
Peer-reviewed paper
Apr 18, 2026
Expert reactions · 0
Sign in to post a take, cite a related claim, or flag a methodological concern.
No reactions yet. Be the first expert to post a take, cite a related claim, or flag a methodological concern.
Source publication
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
Rasha Al-Lamee et al. · The Lancet · 2018
· openalex W2766491028 · s2 1ba069c9
Semantically related
Nearest claims in the expert-corpus vector space. Ordered by cosine distance — lower is closer.
0.0838
Recent follow-up analyses of EMPEROR-Reduced are confirming the original effect size in real-world data.
0.0874
Recent follow-up analyses of ESCAPE are confirming the original effect size in real-world data.
0.0879
Recent follow-up analyses of SWIFT PRIME are confirming the original effect size in real-world data.
0.0895
Recent follow-up analyses of REVASCAT are confirming the original effect size in real-world data.
0.0903
Recent follow-up analyses of EXTEND-IA are confirming the original effect size in real-world data.
0.0904
Recent follow-up analyses of PARADIGM-HF are confirming the original effect size in real-world data.